Dimitrios T Boumpas

发表

Association of IRF5 polymorphisms with increased risk for systemic lupus erythematosus in population of Crete, a southern-eastern European Greek island.

Jessica M. Dorschner, J. Dorschner, T. Niewold, 2017, Gene.

EULAR recommendations for the management of systemic lupus erythematosus: 2023 update

D. Gladman, E. Svenungsson, F. Houssiau, 2023, Annals of the Rheumatic Diseases.

Functional, molecular and proteomic characterisation of bone marrow mesenchymal stem cells in rheumatoid arthritis

S. Lehmann, J. Ringe, C. Jorgensen, 2007, Annals of the rheumatic diseases.

Is systemic lupus erythematosus different in urban versus rural living environment? Data from the Cretan Lupus Epidemiology and Surveillance Registry

L. Chatzi, S. Kazadzis, N. Mihalopoulos, 2018, Lupus.

Extended report: Evidence for treating rheumatoid arthritis to target: results of a systematic literature search

D. Heijde, R. Knevel, D. Aletaha, 2010 .

Sustained improvement of vascular endothelial function during anti‐TNFα treatment in rheumatoid arthritis patients

P. Sidiropoulos, D. Tsetis, P. Siakka, 2009, Scandinavian journal of rheumatology.

Treatment modalities and drug survival in a systemic sclerosis real-life patient cohort

P. Sfikakis, P. Voulgari, A. Drosos, 2020, Arthritis Research & Therapy.

Management of systemic lupus erythematosus: a systematic literature review informing the 2023 update of the EULAR recommendations

C. Mukhtyar, G. Bertsias, A. Fanouriakis, 2024, Annals of the rheumatic diseases.

Single-cell transcriptomic analysis of hematopoietic progenitor cells from patients with systemic lupus erythematosus reveals interferon-inducible reprogramming in early progenitors

S. Giannouli, A. Banos, M. Grigoriou, 2024, Frontiers in immunology.

Disentangling the riddle of systemic lupus erythematosus with antiphospholipid syndrome: blood transcriptome analysis reveals a less-pronounced IFN-signature and distinct molecular profiles in venous versus arterial events

D. Nikolopoulos, G. Bertsias, A. Fanouriakis, 2024, Annals of the rheumatic diseases.

Transcriptomic and proteomic profiling reveals distinct pathogenic features of peripheral non-classical monocytes in systemic lupus erythematosus.

A. Fanouriakis, A. Banos, N. Kapsala, 2023, Clinical immunology.

Response to: Correspondence on ‘EULAR recommendations for the management of systemic lupus erythematosus: 2023 update’ by Fanouriakis et al

G. Bertsias, A. Fanouriakis, M. Kostopoulou, 2024, Annals of the rheumatic diseases.

Clinical and financial burden of active lupus in Greece: a nationwide study

P. Sfikakis, A. Drosos, D. Vassilopoulos, 2016, Lupus.

EULAR points to consider for conducting clinical trials in systemic lupus erythematosus: literature based evidence for the selection of endpoints

J. Ioannidis, C. Gordon, D. Isenberg, 2008, Annals of the rheumatic diseases.

Association of the PTPN22 R620W polymorphism with increased risk for SLE in the genetically homogeneous population of Crete

T. Niewold, M. Zervou, G. Goulielmos, 2011, Lupus.

Pragmatic targets for moderate/severe SLE and their implications for clinical care and trial design: sustained DORIS or LLDAS for at least 6 months is sufficient while their attainment for at least 24 months ensures high specificity for damage-free progression

A. Bortoluzzi, G. Bertsias, A. Fanouriakis, 2024, Annals of the Rheumatic Diseases.

Evolving phenotype of systemic lupus erythematosus in Caucasians: low incidence of lupus nephritis, high burden of neuropsychiatric disease and increased rates of late-onset lupus in the ‘Attikon’ cohort

D. Nikolopoulos, D. Boumpas, A. Fanouriakis, 2020, Lupus.

Enhanced medullary and extramedullary granulopoiesis sustain the inflammatory response in lupus nephritis

P. Pavlidis, G. Gasparoni, A. Banos, 2024, Lupus Science & Medicine.

Investigation of the genetic overlap between rheumatoid arthritis and psoriatic arthritis in a Greek population

A. Barton, D. Kardassis, E. Eliopoulos, 2017, Scandinavian journal of rheumatology.